Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nam H Dang

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Cancer Investigation|September 21, 2007
Denileukin diftitox as novel targeted therapy for lymphoid malignanciesBryan Y Wong, Stephanie A Gregory, Nam H Dang
Advances in Clinical Chemistry|March 17, 2011
Dipeptidyl peptidase in autoimmune pathophysiologyKei Ohnuma, Osamu Hosono, Nam H Dang, et al.
Modern Rheumatology|January 7, 2014
CD26: a key molecule in immune regulation and autoimmune diseasesOsamu Hosono, Kei Ohnuma, Nam H Dang, et al.
Cureus|March 29, 2021
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological FunctionsKelsey Pan, Kei Ohnuma, Chikao Morimoto, et al.
American Journal of Hematology|April 3, 2008
De novo maintenance therapy with denileukin diftitox (Ontak) in a patient with peripheral T-cell lymphoma is associated with prolonged remissionBryan Y Wong, Yupo Ma, Robert Fitzwilson, et al.
Biochemical and Biophysical Research Communications|April 4, 2009
CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cellsHiroto Yamazaki, Hiroko Nishida, Satoshi Iwata, et al.
Cureus|June 7, 2021
Secondary Gamma-Delta T-Cell Lymphoma Not Otherwise Specified (NOS) From Chronic ImmunosuppressionMadeleine E Turcotte, Amar H Kelkar, Joanna Chaffin, et al.
Immunology|November 2, 2012
CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine productionRyo Hatano, Kei Ohnuma, Junpei Yamamoto, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphomaHiroyuki Kayo, Hiroto Yamazaki, Hiroko Nishida, et al.
Mini Reviews in Medicinal Chemistry|March 10, 2007
CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disordersMichael A Thompson, Kei Ohnuma, Masako Abe, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Cancer Investigation|September 21, 2007
Denileukin diftitox as novel targeted therapy for lymphoid malignanciesBryan Y Wong, Stephanie A Gregory, Nam H Dang
Advances in Clinical Chemistry|March 17, 2011
Dipeptidyl peptidase in autoimmune pathophysiologyKei Ohnuma, Osamu Hosono, Nam H Dang, et al.
Modern Rheumatology|January 7, 2014
CD26: a key molecule in immune regulation and autoimmune diseasesOsamu Hosono, Kei Ohnuma, Nam H Dang, et al.
Cureus|March 29, 2021
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological FunctionsKelsey Pan, Kei Ohnuma, Chikao Morimoto, et al.
American Journal of Hematology|April 3, 2008
De novo maintenance therapy with denileukin diftitox (Ontak) in a patient with peripheral T-cell lymphoma is associated with prolonged remissionBryan Y Wong, Yupo Ma, Robert Fitzwilson, et al.
Biochemical and Biophysical Research Communications|April 4, 2009
CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cellsHiroto Yamazaki, Hiroko Nishida, Satoshi Iwata, et al.
Cureus|June 7, 2021
Secondary Gamma-Delta T-Cell Lymphoma Not Otherwise Specified (NOS) From Chronic ImmunosuppressionMadeleine E Turcotte, Amar H Kelkar, Joanna Chaffin, et al.
Immunology|November 2, 2012
CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine productionRyo Hatano, Kei Ohnuma, Junpei Yamamoto, et al.
Biochemical and Biophysical Research Communications|November 6, 2007
Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphomaHiroyuki Kayo, Hiroto Yamazaki, Hiroko Nishida, et al.
Mini Reviews in Medicinal Chemistry|March 10, 2007
CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disordersMichael A Thompson, Kei Ohnuma, Masako Abe, et al.
Pageof 13